长期扩增人肝细胞去分化相关炎症因子加剧其移植时被巨噬细胞清除
研究探讨长期扩增的人肝细胞(ProliHH)移植效率下降的机制,发现长期培养的ProliHH(lc-ProliHH)上调去分化相关炎症因子(DAIF),引发过度巨噬细胞反应导致清除。地塞米松阻断固有免疫或类器官再成熟可改善移植与再增殖,提高肝功能和生存。
要点
- 长期培养的ProliHH上调DAIF,引发巨噬细胞过度反应而在移植中被清除。
- 地塞米松阻断固有免疫可恢复lc-ProliHH移植与再增殖至原代肝细胞水平。
- 将lc-ProliHH再成熟为类器官可降低DAIF表达并显著改善移植。
核心结论
- lc-ProliHH通过DAIF触发加剧的巨噬细胞活化,为lc-ProliHH临床移植提供了潜在解决方案。
研究设计与样本
- 基础研究,使用长期扩增的人肝细胞(ProliHH)及延胡索酰乙酰乙酸水解酶缺陷小鼠进行移植实验。
主要发现
- 长期培养的ProliHH(lc-ProliHH)伴随去分化上调一组与固有免疫相关的趋化因子和细胞因子,称为去分化相关炎症因子(DAIF)。
- DAIF引发过度巨噬细胞反应,导致lc-ProliHH在移植期间被特异性清除。
- 地塞米松阻断固有免疫反应使lc-ProliHH的移植和再增殖恢复到与原代肝细胞相当的水平,并改善延胡索酰乙酰乙酸水解酶缺陷小鼠的肝功能和生存。
- 将lc-ProliHH再成熟为类器官降低了DAIF表达并显著改善移植。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocyte transplantation has been demonstrated to be effective to treat liver metabolic disease and acute liver failure. Nevertheless, the shortage of donor hepatocytes restrained its application in clinics. To expand human hepatocytes at a large scale, several dedifferentiation-based protocols have been established, including proliferating human hepatocytes (ProliHH). However, the decreased transplantation efficiency of these cells after long-term expansion largely impedes their application. APPROACH AND RESULTS: We found that accompanied with dedifferentiation, long-term cultured ProliHH (lc-ProliHH) up-regulated a panel of chemokines and cytokines related to innate immunity, which were referred to as dedifferentiation-associated inflammatory factors (DAIF). DAIF elicited excessive macrophage responses, accounting for the elimination of lc-ProliHH specifically during engraftment. Two possible strategies to increase ProliHH transplantation were then characterized. Blockage of innate immune response by dexamethasone reverted the engraftment and repopulation of lc-ProliHH to a level comparable to primary hepatocytes, resulting in improved liver function and a better survival of fumarylacetoacetate hydrolase-deficient mice. Alternatively, rematuration of lc-ProliHH as organoids reduced the expression of DAIF and led to markedly improved engraftment. CONCLUSIONS: These results revealed that lc-ProliHH triggers exacerbated macrophage activation by DAIF and provided potential solutions for clinical transplantation of lc-ProliHH.
引用
- Wang C, Zhang L, Sun Z, et al. Dedifferentiation-associated inflammatory factors of long-term expanded human hepatocytes exacerbate their elimination by macrophages during liver engraftment. Hepatology. 2022. PMID: 35229337. doi:10.1002/hep.32436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。